About Rob Kniaz
Form D filings for PharmaCCX in 2023 list Rob Kniaz as director.
Rob Kniaz first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Rob Kniaz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Rob Kniaz works with at each company, as listed on that company's latest Form D.
PharmaCCX, Inc. · Form D, Jul 18, 2023
PR
Peter Rice
President
NS
Nathan Sigworth
Executive officer and director
JB
Julia Bernstein
Director
BS
Barath Subramanian
Director